Clearmind Medicine Inc. (CMND)
NASDAQ
$0.8030−$0.0073 (−0.90%) on the dayAs of the close; data may be delayed.
CMND price, last 12 months
Key stats
- Previous close
- $0.8103
- Open
- $0.8400
- Day range
- $0.8021 – $0.8400
- 52-week range
- $0.7700 – $480.00
- Volume
- 58.1K
- Avg volume (20 days)
- 1.2M
- Market cap
- $2.7M
Performance
1W+0.5%
1M−53.3%
3M−66.3%
6M−89.1%
YTD−95.6%
1Y−99.8%
vs S&P 500, 1Y−116.6 pts
Technicals and fundamentals
About Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
- Listed on
- NASDAQ
- Market cap
- $2.7M